Tharimmune, Inc.
THAR
$1.64
$0.042.50%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 20.20% | 2.48% | 6.94% | 3.94% | 6.20% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 39.01% | 31.50% | 27.93% | 1.38% | 10.22% |
| Operating Income | -39.01% | -31.50% | -27.93% | -1.38% | -10.22% |
| Income Before Tax | -40.47% | -30.89% | -26.00% | 0.49% | -8.12% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -40.47% | -30.89% | -26.00% | 0.49% | -8.12% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -40.47% | -30.89% | -26.00% | 0.49% | -8.12% |
| EBIT | -39.01% | -31.50% | -27.93% | -1.38% | -10.22% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 92.36% | 94.96% | 92.34% | 79.31% | 60.81% |
| Normalized Basic EPS | 92.36% | 94.96% | 92.34% | 79.31% | 60.81% |
| EPS Diluted | 92.36% | 94.96% | 92.34% | 79.31% | 60.81% |
| Normalized Diluted EPS | 92.36% | 94.96% | 92.34% | 79.31% | 60.81% |
| Average Basic Shares Outstanding | 468.46% | 1,367.18% | 2,277.97% | 1,450.18% | 881.40% |
| Average Diluted Shares Outstanding | 468.46% | 1,367.18% | 2,277.97% | 1,450.18% | 881.40% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |